I'm riding: Metric Century

Team: Commerce Bank Challenge Accepted

ID: 111165

Lifetime total: $707.50


I am riding In Honor of Matt Vincenti.

WHY I RIDE

My husband, Daniel, and I are riding in Pedal the Cause at the end of September. Pedal the Cause is an organization that raises money for cancer research through a sponsored cycling event each fall. 100% of funds raised go to support research at Siteman Cancer Center and Siteman Kids at Barnes-Jewish Hospital and Washington University School of Medicine. (Pedal = Cycling | The Cause = A World Without Cancer)

?The Cause? is a good one. Everyone reading this has been affected by cancer in some way. Daniel and I both have lost young friends to this disease. The trouble can be finding an effective way to contribute.

While we both love to ride, we?ve chosen this particular event because we believe that Siteman Cancer Center pushes the envelope in cancer research globally and is wholly dedicated to effective, personal patient care in St. Louis locally.

Siteman is an international leader in cancer treatment, research, prevention, education and community outreach. Siteman also has the nation?s largest clinical research program, which offers innovative, therapeutic treatments for patients with cancers that were previously considered untreatable. I?ve included a sampling of Siteman?s contributions to the cause at the end of this note (a few of my favorites), but I encourage you to visit their website and read them all. The progress they?ve made from right here in St. Louis is quite impressive.

Daniel and I have committed to raising $600 and $500 respectively for each of our races, but we?d love to go above and beyond the minimum required to participate. Please consider joining us and contributing to this great cause!

-------

Taken from the Siteman Cancer Center website:

1950: Evarts A. Graham, MD, and medical student Ernst Wynder publish a landmark study that provides the first evidence linking smoking and lung cancer.

1972: Investigators at WashU School of Medicine invent positron emission tomography (PET) imaging, which shows physiological activity rather than anatomical form.

1974: Mallinckrodt Institute of Radiology joins forces with London-based EMI, Ltd. to develop the prototype of the first CT head scanner.

1990: Stanley J. Korsmeyer, MD, uncovers an important new mechanism for cancer development with the discovery that the gene ?bcl-2? blocks the naturally occurring cell suicide process known as ?programmed cell death.? This work led to a Nobel Prize.

1991: Mallinckrodt Institute of Radiology opens St. Louis? first 3-D cancertreatment planning center. This technique allows physicians to tailor radiation therapy while minimizing damage to normal tissues.

2004: Siteman Cancer Center is awarded the prestigious Comprehensive Cancer Center designation from the National Cancer Institute placing Siteman among the most highly ranked cancer institutions in the nation.

2011: Siteman Cancer Center performs its 5,000th bone marrow transplant, placing it among the top five cancer centers in the United States. [This number is now more that 7,500 with the program performing nearly 500 transplants each year.]

2016: Siteman and St. Louis Children?s Hospital establish ?Siteman Kids at St. Louis Children?s Hospital,? a partnership focused on caring for children and adolescents with cancer, using the latest, most effective treatments, in a setting geared to younger patients and their families.


MY PTC HISTORY

2018
2019